MDMA Decision Debrief Webinar

Join us for an exclusive hour with Fluence Co-Founders, Ingmar Gorman PhD and Elizabeth Nielson PhD, who served as principal investigators and study therapists on the MAPS clinical trials looking at the efficacy of MDMA for PTSD, to unpack the FDA’s announcement on the status of MDMA which is expected by August 12.